Right, because taking 5 covid tests a week is equivalent to a yearly mammogram! False equivalency anyone?
Rail against DeSantis and Florida, come to Florida - ditch your masks and enjoy your freedoms. Go home and test positive. the Democrat way, I guess.
oof, total clown show. Imagine being a MAGGAT, doubling down on stupid and hitching your wagon to the new circus in town?
Yet you have nothing to say about DeSantis' recent failures -- including but not limited to: One million expired test kits. Pawning off expired test kits on seniors and teachers. The Tampa Bay Times revealing that the federal government had not cut the shipment of monoclonal antibody treatments to Florida despite Regeneron Ron's continual fabrications, lying and whining about it. Of course, Regneron Ron is demanding more Regeneron -- a treatment which is totally ineffective against Omicron. Record Covid cases nearly every day in the past two weeks with hospitalizations quickly rising. Of course when faced with record cases, little Ron's answer is people with symptoms should not get tested -- which was quickly mocked by the medical community as absurd. Not content to kill Florida residents, Regeneron Ron threatens to fine hospitals which have vaccine mandates. And of course DeSantis came out in support of the January 6th insurrectionists. But "Freedum" - whatever. And while you are at it remember to remind "South Florida Trophy Wife" that her "dear friend" can't get monoclonal antibody treatment in North Carolina by calling the "telehealth MD" who provides their Ivermectin (which obviously failed for them).
Because all you post is narratives. I don't waste time running them all down to show you how stupid they are, because you want to be stupid. So who am I to try to educate you?
So mirroring his behavior at the beginning of 2021 when DeSantis sent vaccines to his wealthy GOP donors -- DeSantis is now sending COVID-19 therapies to his wealthy GOP donors. Florida sent scarce COVID-19 therapy to a private Broward clinic before Jackson Memorial https://www.miamiherald.com/news/coronavirus/article257194187.html Florida shipped a scarce new COVID-19 monoclonal antibody drug to treat the most vulnerable of patients — those with cancer or organ transplants whose immune systems don’t respond well to a vaccine — to a private clinic in Broward County before sending the therapeutic to Miami’s Jackson Memorial Hospital, which runs the largest solid organ transplant center in the Southeastern United States and provides follow-up care to thousands of immuno-compromised patients. In December, Florida’s health department shipped 264 doses of a drug called Evusheld to a limited liability company that was incorporated in March 2020 and advertises house calls and COVID-19 testing, vaccination and therapy on its website. But the state did not send a shipment to Jackson Memorial until January, when the hospital received a total of 192 doses, according to federal data. The private clinic, iCare Mobile Medicine, received more Evusheld in the state’s first shipment than any other hospital or medical provider in Florida. Dr. Nicholas Suite, a neurologist and medical director of iCare Mobile Medicine, did not respond to phone calls and an email from the Herald requesting an interview on Monday. But Suite told STAT News, which first reported on iCare’s shipment of Evusheld, that the therapeutics arrived at his office on Dec. 24, and that since announcing its availability the phone has not stopped ringing with requests. Florida’s health department has refused the Herald’s requests to explain the state’s prioritization plan for distributing Evusheld and other COVID-19 therapeutics received from the federal government. South Florida hospitals have more patients in need of monoclonal antibodies to treat COVID-19 than they have supplies of the scarce drugs, forcing some medical centers to prioritize one of the most vulnerable groups for treatment — individuals whose immune system does not respond well to a vaccine. For these patients, Evusheld can provide up to six months of protection against COVID-19, according to the Food and Drug Administration, which authorized the treatment for emergency use on Dec. 8. But Evusheld is scarce, and the supply is controlled by the federal government, which has shipped more than 6,300 doses to Florida, whose health department decides where to send the therapeutic and how many of the requested doses each medical provider will receive. According to the federal Department of Health and Human Services’ online locator for COVID-19 therapeutics, Florida’s first shipments of Evusheld skipped all South Florida hospitals, though medical centers in Ocala, Tampa and Gainesville also were among the first to receive the drug. Miami-Dade and Broward counties have recorded the state’s highest number of new COVID cases, per capita, during the omicron surge. NO SOUTH FLORIDA HOSPITAL OTHER THAN JACKSON RECEIVED SHIPMENT BY JAN. 6 No South Florida hospital other than Jackson Memorial has received a shipment of Evusheld as of Jan. 6, the federal data shows. However, the federal government has yet to report where Florida has distributed more than 4,700 doses of Evusheld shipped to the state since Dec. 27. Jackson Health System, Miami-Dade’s public hospital network, which runs the Miami Transplant Institute in partnership with the University of Miami Health System, declined an interview request from the Herald regarding Evusheld and the significance of the new therapeutic for its patients. The Miami Transplant Institute is one of the busiest solid organ transplant hospitals in the nation, performing more than 400 transplants during the year that ended June 30, 2021, according to federal data. Doctors at the center also provide follow-up care for many more organ transplant recipients — more than 2,660 in 2020-2021 — all of whom are prescribed immunosuppressant drugs to prevent their bodies from rejecting the donor organ. Many patients who take immunosuppressant drugs do not build adequate immunity to the coronavirus after vaccination. CHICAGO DOCTOR HAS PATIENTS WHO WERE TREATED AT BROWARD CLINIC Dr. Michael G. Ison, a specialist in infectious disease and organ transplant surgery at Northwestern University’s Feinberg School of Medicine in Chicago, said transplant centers are ideally suited to distribute Evusheld, a drug for which there are many more patients who would benefit than there is of the medication itself. “It’s the providers that are caring for those patients that can help better understand which of those patients probably should be prioritized above others for getting the drug,” Ison said. “In fact, most transplant centers and expert groups have recommended a tiered structure where certain higher risk individuals get access to the drug first,” he said, “and that is best accomplished through the centers that are caring for these patients because, A) they’ve given them the drugs that put them in the situation they’re in needing this therapy, and B) they have the best set of data to understand which patients will receive the best benefit and therefore should be prioritized.” Ison said he worried that patients who truly need Evusheld may not be able to access the drug if it’s put in the hands of a small medical practice that doesn’t have access to a broad range of patients with immunocompromised conditions. “They will allow it to be given to anyone including people that may not be residents of the state, thereby kind of offering the drug to patients that are lower risk before those that are higher risk have a chance to get them,” he said. Evusheld, manufactured by AstraZeneca Pharmaceuticals, is administered as two separate and consecutive intramuscular injections. It is free to patients, though providers may bill a patient’s health insurance for administering the drug. STAT News reported that Suite said he follows the FDA and the manufacturer’s criteria for administering Evusheld and that he does not provide the drug to permanent residents of other states. But Ison said he learned about iCare providing Evusheld from his patients in Chicago who traveled to South Florida to receive the drug from the private clinic. Northwestern Memorial Hospital in Chicago will get its first doses this week, he said. “The real question is in the state of Florida how did that site get the drug but the largest transplant center didn’t? Clearly someone made a decision,” Ison said. BROWARD HEALTH HAS NOT RECEIVED COVID TREATMENT At Broward Health, the public hospital system for North Broward, doctors have not received a shipment of Evusheld although the hospital could use the drug for patients who receive liver and kidney transplants. Dr. Joshua Lenchus, Broward Health’s chief medical officer, said physicians have started to prioritize certain high risk patients with underlying medical conditions and who test positive for COVID-19 for monoclonal antibody treatments. But the hospital has only received Regeneron’s monoclonal antibodies, a product called REGEN-COV, Lenchus said, and not Evusheld or another monoclonal antibody that is known to be most effective against the omicron variant, a drug called sotrovimab. Lenchus said REGEN-COV is indicated for people who may have been exposed to someone who is infectious, and who are at high risk of developing severe disease due to an underlying medical condition. But the hospital stopped using the Regeneron product for post exposure cases in order to preserve the drug for those who have been diagnosed with COVID-19. “What we’ve really been doing, because the supply is pretty scarce, is we’ve really been earmarking those other monoclonal antibodies, REGEN-COV and sotrovimab, if we get it, for those people who actually test positive.” In the same way that hospitals must allocate scarce medical treatments, Florida’s health department is responsible for developing and communicating an equitable system for distributing a potentially life-saving drug during a pandemic, said Kenneth Goodman, who founded and directs the University of Miami Miller School of Medicine’s Institute for Bioethics and Health Policy. ‘LACK OF TRANSPARENCY’ IN FLORIDA’S COVID DECISIONS, MIAMI DOCTOR SAYS “ All of this potentially useful therapeutics and an environment of scarcity is occurring under a complete lack of transparency,” said Goodman, who also is director of the Florida Bioethics Network, which has published guidelines for managing shortages of COVID-19 therapeutics in hospitals. “Any decision about how to allocate a scarce resource is one that we’ve been working on for more than two years now, as have the ethics communities in 49 other states,” Goodman said. “In some states they actually listen. In some states, including Florida, they don’t.” Goodman said there are different ways to figure out a fair distribution system for a scarce resource, but that the guidelines are pretty straightforward. He emphasized that transparency is key. “Overall,” he said, “it’s reasonable to say how much have you got, where are you sending it and why, and how did you decide.“
This was a funny post dispelling this silly narrative: https://threadreaderapp.com/thread/1480778005798866945.html Cancer Slayer 8h, 14 tweets, 6 min read Let me help you here, @dchangmiami. As one of many immunocompromised patients who received the Evusheld antibodies at @IcareMedicine, I feel blessed. It wasn’t easy, but it could have been if BidenCo could find their backsides with both hands. They can’t. 1/ Evusheld is an important treatment made available by @GovRonDeSantis and @FLSurgeonGen Joseph Ladapo for immunocompromised Floridians including cancer recovery patients like me. I was vaxed 3 times with Moderna but an antibodies test revealed that I had zero B cell immunities. 2/ This was a shock for our family. Still in the early stages of my cancer recovery it was a real possibility I might get sick with Omicron. I called many hospitals; I couldn’t get a human on the phone. (Are you surprised?) The first place to even talk to me was @IcareMedicine. 3/ I’ll admit to being a bit reluctant to get such a vital treatment outside a hospital setting but iCare made it easy to get an appointment in a reasonable amount of time. I didn’t have to sit on the phone on hold; their text sign-up system was very convenient and worked well. 4/ We showed up on time and @IcareMedicine was ready for me immediately. It was obvious right away they knew exactly what they were doing. The paperwork was simple and I was in front of a medical specialist for the treatment within 10 minutes. He told me something interesting. 5/ Apparently when @HealthyFla called iCare they said they had to hold off sending Evusheld because they feared the doses would sit around through Christmas, maybe even without proper storage, because hospitals told them they would be unavailable through the holiday. Not iCare. 6/ Dr. Nicholas Suite of @IcareMedicine slept at his clinic on Christmas Eve away from his family to make sure the Evusheld doses were properly received and his team went to work right away. I got my first text offering the dosage on Christmas Day. Where were you that day, Dan? 7/ I signed up for my Evusheld appointment on their Web site while my daughters unwrapped their presents. The page was super busy; as I picked a day/time the appointment would disappear. I got one pretty fast though. My wife and I planned to get to their office New Year’s Eve. 8/ Where were you New Year’s Eve Dan? Were the complaining hospital doctors waiting for patients in their parking lot to triage them for a lifesaving COVID treatment? Were they working until dark assuring immunocompromised patients were protected from COVID or chilling champagne? 9/ As a former Assistant Secretary at the US Department of Health and Human Services during the pandemic, I truly appreciate the professionalism and expertise of @IcareMedicine and I am deeply thankful for their help. BidenCo, not so much. They bungled Evusheld provisioning. 10/ Did you ask why Florida had to wait so damn long for Evusheld doses Dan? I guess not. I know why because I was there for the 2020 provisioning of Remdesivir as the pandemic burned - the bureaucrats couldn’t get out of their own way. And now Biden intentionally got in the way. 11/ Did you ask why BidenCo intentionally broke the monoclonal antibody distribution system @GovRonDeSantis built to save Floridian lives months ago? No. Did you ask why months later supplies were still short and then not even available? Why do vulnerable people have to scramble? 12/ A bunch of hospitals who never put live people on the phones and who give no answers except “call later” when a human does pick up were unwilling to work on a holiday to take deliveries, Dan. @IcareMedicine was there. I’m sure @HealthyFla workers were there the whole way too. 13/ You wrote a story any J-school kid could write: find complainers, don’t ask the right questions, transcribe the anti-DeSantis narrative and avoid the real story: @HealthyFla and places like @IcareMedicine busted there asses to get Evusheld out while you all had your holiday. END
So your answer is to point out that a DeSantis supporter and donor outlines how he got Evusheld from a private doctor concierge service owned by a wealthy GOP donor -- a firm which somehow also got Evusheld when none is available to hospitals serving the commoners. It is just a sad additional to this tale of preferential treatment for the rich from the DeSantis administration.